enoxolone   Click here for help

GtoPdb Ligand ID: 11264

Synonyms: 18β-Glycyrrhetinic acid | glycyrrhetic acid | glycyrrhetinic acid
PDB Ligand
Compound class: Synthetic organic
Comment: Enoxolone is a bioactive metabolite of glycyrrhizin, which is a compound found in the liquorice plant Glycyrrhiza glabra. It has been found to inhibit enzymes that metabolise the prostaglandins PGE2 and PGF to their inactive metabolites, and 11β-hydroxysteroid dehydrogenases (HSD11B1, HSD11B2) which convert active cortisol to inactive cortisone. Enoxolone has proposed anti-inflammatory [4-5,7,9] and antitussive effects as well as action against pathogens (viruses, fungal infections, bacterial infections) [1,3], and beneficial actions for the treatmant of gastric ulcers.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 1
Topological polar surface area 74.6
Molecular weight 470.34
XLogP 6.75
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=C1C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@]2([C@]2([C@H]1[C@@]1(C)CC[C@@H](C([C@@H]1CC2)(C)C)O)C)C)C(=O)O
Isomeric SMILES O=C1C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@]2([C@]2([C@H]1[C@@]1(C)CC[C@@H](C([C@@H]1CC2)(C)C)O)C)C)C(=O)O
InChI InChI=1S/C30H46O4/c1-25(2)21-8-11-30(7)23(28(21,5)10-9-22(25)32)20(31)16-18-19-17-27(4,24(33)34)13-12-26(19,3)14-15-29(18,30)6/h16,19,21-23,32H,8-15,17H2,1-7H3,(H,33,34)/t19-,21-,22-,23+,26+,27-,28-,29+,30+/m0/s1
InChI Key MPDGHEJMBKOTSU-YKLVYJNSSA-N
No information available.
Summary of Clinical Use Click here for help
Enoloxone is a component of OTC medications in many countries, that are use topically for minor inflammatory skin and oral/throat conditions. Enoloxone is being evaluated in clinical studies.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT02939144 An Investigation Into the Effect of Liquorice Ingestion on the Salivary Cortisol to Cortisone Molar Ratio N/A Interventional The Royal Wolverhampton Hospitals NHS Trust
NCT00759525 The Role of Mineralocorticoid Receptors in Vascular Function Phase 2/Phase 3 Interventional Brigham and Women's Hospital
NCT03998982 Glycyrrhetinic Acid Combined With Dexamethasone in Management of Newly Diagnosed ITP Phase 4 Interventional Shandong University